Ads
related to: latest news on herpes cure coming soon
Search results
Results From The WOW.Com Content Network
(Reuters) -British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to ...
Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development , vaccines and genome editing.
Pritelivir (development codes AIC316 or BAY 57-1293) is a direct-acting antiviral drug in development for the treatment of herpes simplex virus infections (HSV). This is particularly important in immune compromised patients. It is currently in Phase III clinical development by the German biopharmaceutical company AiCuris Anti-infective Cures AG.
For premium support please call: 800-290-4726 more ways to reach us
NV1020 is an oncolytic herpes virus initially developed by Medigene Inc. and licensed for development by Catherex Inc. in 2010. [17] NV1020 has a deletion of just one copy of the ICP34.5 gene and ICP6 is intact. [1] A direct comparison of NV1020 and G207 in a mouse model of peritoneal cancer showed that NV1020 is more effective at lower doses. [18]
Herpes infections can lead to recurring, often painful, blisters. About half a billion people ages 15 to 49 have genital herpes infections, which are mostly caused by herpes simplex virus type 2 ...